IS 33. NBS in schizophrenia

Conclusions: These pilot data suggest that bilateral rTMS may be a novel, efficacious, and safe treatment for working memory deficits in patients with schizophrenia. rTMS for the treatment on neurophysiology and non-cognitive symptoms for schizophrenia will also be reviewed in the context of this trial. (Source: Clinical Neurophysiology)

Source: http://www.medworm.com/index.php?rid=7608787&cid=u_0_168_f&fid=38452&url=http%3A%2F%2Fwww.clinph-journal.com%2Farticle%2FS1388-2457%2813%2900354-4%2Fabstract%3Frss%3Dyes

online phlebotomy courses phlebotomy online courses accredited phlebotomy schools